- Home
- GMED vs CHRW Comparison
GMED vs CHRW Comparison
Compare GMED & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- CHRW
- Stock Information
- Founded
- GMED 2003
- CHRW 1905
- Country
- GMED United States
- CHRW United States
- Employees
- GMED N/A
- CHRW N/A
- Industry
- GMED Medical/Dental Instruments
- CHRW Oil Refining/Marketing
- Sector
- GMED Health Care
- CHRW Consumer Discretionary
- Exchange
- GMED Nasdaq
- CHRW Nasdaq
- Market Cap
- GMED 11.6B
- CHRW 12.9B
- IPO Year
- GMED 2012
- CHRW 1997
- Fundamental
- Price
- GMED $84.79
- CHRW $108.91
- Analyst Decision
- GMED Buy
- CHRW Buy
- Analyst Count
- GMED 14
- CHRW 17
- Target Price
- GMED $90.69
- CHRW $113.07
- AVG Volume (30 Days)
- GMED 822.2K
- CHRW 1.2M
- Earning Date
- GMED 11-05-2024
- CHRW 01-29-2025
- Dividend Yield
- GMED N/A
- CHRW 2.27%
- EPS Growth
- GMED N/A
- CHRW N/A
- EPS
- GMED 0.67
- CHRW 2.89
- Revenue
- GMED $2,478,596,000.00
- CHRW $17,762,187,000.00
- Revenue This Year
- GMED $62.39
- CHRW $4.28
- Revenue Next Year
- GMED $6.71
- CHRW $2.13
- P/E Ratio
- GMED $124.29
- CHRW $37.65
- Revenue Growth
- GMED 102.10
- CHRW N/A
- 52 Week Low
- GMED $49.33
- CHRW $65.00
- 52 Week High
- GMED $87.22
- CHRW $114.82
- Technical
- Relative Strength Index (RSI)
- GMED 60.22
- CHRW 50.83
- Support Level
- GMED $81.42
- CHRW $106.54
- Resistance Level
- GMED $84.16
- CHRW $114.82
- Average True Range (ATR)
- GMED 1.70
- CHRW 2.83
- MACD
- GMED -0.40
- CHRW 0.18
- Stochastic Oscillator
- GMED 48.28
- CHRW 40.84
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.